CD8A and infection: Then, the ability of CD8+ cells to suppress replication of SIVs derived from autologous PBMCs post-ART (referred to as post-ART SIV) was examined by using post-ART CD8- cells obtained at week 34 post-infection from individual Group V animals as the target cells (Fig. 6a).